Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
News
€ 38.28
Key Takeaways
Risk factor
Low price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Weak margins and returns
Data is available to registered users only
Data is available to registered users only
About
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/E
Data is available to registered users only
Buy
Sell